Interestingly, our study of PTPN22 splice form expression in MS patients did not show a similar effect, which is in line with the fact that this disease is not associated with polymorphisms in the PTPN22 gene and supports disease specificity [2,26-29]. Here, PTPN22 is linked to myeloid sarcoma.